Weichai Power (02338) plans to repurchase and cancel 820,000 restricted shares.
Weichai Power (02338) announced that, due to job transfers and retirement of 8 original incentive recipients in this incentive plan...
Weichai Power (02338) announced that, due to job transfers, retirement, resignations, and other situations of 8 original incentive recipients in the current incentive plan, it has agreed to repurchase and cancel a total of 820,000 A shares of restricted stocks held by them that have been granted but not yet released from restriction. The company will also pay bank deposit interest to 6 of these individuals. The total amount for the repurchase of restricted stocks is approximately RMB 4.3066 million, along with corresponding bank deposit interest, which will be funded by the company's own funds.
Related Articles

SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.

On July 2, MNSO (09896) spent $231,100 to repurchase 51,200 shares.
SIMCERE PHARMA(02096): Enze Shu has been approved by the National Medical Products Administration to be launched in China.

SIRNAOMICS-B (02257): Ouyang Yunlong appointed as non-executive director.

On July 2, MNSO (09896) spent $231,100 to repurchase 51,200 shares.

RECOMMEND

U.S. Senate Passes “Big and Beautiful” Bill, Triggering Surge in Gold Amid Soaring Deficit Concerns
02/07/2025

Declining Demand Triggers Price Drop; Photovoltaic Glass Industry May Be Preparing for a New Round of Coordinated Production Cuts
02/07/2025

Surge in Prices of Chinese-Made Goods Highlights Tariff Impact on U.S. Consumers
02/07/2025